Dr. Saltz Discusses FOLFIRINOX in Colorectal Cancer

Video

In Partnership With:

Leonard Saltz, MD, executive director for Clinical Value & Sustainability, head, Colorectal Oncology Section, Memorial Sloan Kettering Cancer Center, discusses the option of FOLFIRINOX for the treatment of patients with metastatic colorectal cancer.

Leonard Saltz, MD, executive director for Clinical Value & Sustainability, head, Colorectal Oncology Section, Memorial Sloan Kettering Cancer Center, discusses the option of FOLFIRINOX for the treatment of patients with metastatic colorectal cancer (CRC).

FOLFIRINOX is a chemotherapy regimen consisting of leucovorin, fluorouracil, irinotecan, and oxaliplatin. It has shown positive data in patients with CRC who have excellent performance status, but Saltz says that there is concern over the dosage of fluorouracil. For example, frontline FOLFIRINOX with or without bevacizumab (Avastin) is the preferred standard-of-care option for patients with CRC who harbor BRAF V600E mutations.

Saltz comments that he uses FOLFIRINOX when he needs a rapid response in terms of tumor regression, but only if the patient is in overall good medical shape. The question of chemothearpy remains complicated in this tumor type, as there are a plethora of treatment options with varying advantages and disadvantages.

Related Videos
Christian Marth, MD, PhD, head, professor, Department of Obstetrics and Gynecology, Innsbruck Medical University
Mansoor Raza Mirza, MD, chief oncologist, Department of Oncology, Rigshospitalet, Copenhagen University Hospital
A panel of 4 experts on colorectal cancer
A panel of 4 experts on colorectal cancer
Judy Hayek, MD, gynecologic oncology fellow, State University of New York (SUNY) Downstate College of Medicine
Leslie M. Randall, MD, MAS, professor, division head, Department of Obstetrics and Gynecology – Gynecologic Oncology, Virginia Commonwealth University School of Medicine Obstetrics and Gynecology
Dimitrios Nasioudis, MD, fellow, Gynecologic Oncology, Perelman School of Medicine, the University of Pennsylvania
Sara Corvigno, MD, PhD, translational researcher, oncology, The University of Texas MD Anderson Cancer Center
I-Chia (Daniel) Liu, MD
Robert W. Mutter, MD